Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

230

Full text

192

Free full text

Publication Types

Journal Article

232

Research Support, Non-U.S. Gov't

Randomized Controlled Trial

Review

Multicenter Study

Clinical Trial

Observational Study

Comparative Study

Research Support, N.I.H., Extramural

Clinical Trial, Phase II

Clinical Trial, Phase III

Clinical Trial, Phase I

Research Support, U.S. Gov't, Non-P.H.S.

Systematic Review

Controlled Clinical Trial

Meta-Analysis

Case Reports

Research Support, U.S. Gov't, P.H.S.

Network Meta-Analysis

Retracted Publication

Evaluation Study

Letter

Validation Study

Video-Audio Media

Clinical Trial Protocol

Pragmatic Clinical Trial

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Pyrrolidines""[mesh_terms]

234 Results

Searching titles within these results

5-(pyrrolidin-2-yl)-1H-tetrazole and 5-[(pyrrolidin-2-yl)methyl]-1H-tetrazole: proline surrogates with increased potential in asymmetric catalysis.

Michael Limbach

Chemistry & biodiversity 2007;3(2):119-33

Full Text

Abstract

Spotlight on intravenous vernakalant in recent-onset atrial fibrillation.

Lesley J Scott, Sean T Duggan

Drugs & aging 2012;28(6):501-4

Full Text

Abstract

Pharmacokinetics, Pharmacodynamics, and Safety of Evocalcet (KHK7580), a Novel Calcimimetic Agent: An Open-Label, Single- and Multiple-Dose, Phase I Trial in Healthy Chinese Subjects.

Chisato Nagai, Masahiro Kojima, Kazuya Narushima, Xuemei He, Kexin Li

Drug design, development and therapy 2024;18():567-581

Free Full Text

Abstract

Physiologically-Based Pharmacokinetic Model Development, Validation, and Application for Prediction of Eliglustat Drug-Drug Interactions.

Shen Cheng, Reena V Kartha, Neal J Weinreb, Jeanine R Jarnes, Siddhee A Sahasrabudhe, Mahmoud Al-Kofahi

Clinical pharmacology and therapeutics 2022;112(6):1254-1263

Free Full Text

Abstract

Enzyme toolbox: novel enantiocomplementary imine reductases.

Philipp N Scheller, Silvia Fademrecht, Sebastian Hofelzer, Jürgen Pleiss, Friedemann Leipold, Nicholas J Turner, Bettina M Nestl, Bernhard Hauer

Chembiochem : a European journal of chemical biology 2015;15(15):2201-4

Full Text

Abstract

Spotlight on eletriptan in migraine.

Gillian M Keating, Paul L McCormack

CNS drugs 2007;20(11):961-4

Full Text

Abstract

Bi-atrial high-density mapping reveals inhibition of wavefront turning and reduction of complex propagation patterns as main antiarrhythmic mechanisms of vernakalant.

Ulrich Schotten, Sander Verheule, Marion Kuiper, Pawel Kuklik, Piotr Podziemski, Stef Zeemering, Arne van Hunnik

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2021;23(7):1114-1123

Free Full Text

Abstract

Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study.

John J Nemunaitis, Ryan Geschwindt, Lance Leopold, Ignacio Garrido-Laguna, Patricia M LoRusso, Solmaz Sahebjam, Wells A Messersmith, Aaron S Mansfield, Jason J Luke, Kai Ding, John D Powderly, Aung Naing, Jordan D Berlin, Michael Smith

Journal for immunotherapy of cancer 2022;10(3):e004223

Free Full Text

Abstract

Structure activity relationship (SAR) and anticancer activity of pyrrolidine derivatives: Recent developments and future prospects (A review).

Runjhun Tandon, Nitin Tandon, Iqubal Singh, Aeyaz Ahmad Bhat

European journal of medicinal chemistry 2023;246():114954

Full Text

Abstract

Future target molecules for influenza treatment.

N Uchide, H Toyoda

Mini reviews in medicinal chemistry 2008;8(5):491-5

Full Text

Abstract

Intravenous vernakalant: a review of its use in the management of recent-onset atrial fibrillation.

Lesley J Scott, Sean T Duggan

Drugs 2011;71(2):237-52

Full Text

Abstract

Investigation of the mechanism of nicotine demethylation in Nicotiana through 2H and 15N heavy isotope effects: implication of cytochrome P450 oxidase and hydroxyl ion transfer.

Roland Molinié, Renata A Kwiecień, Piotr Paneth, Wilfried Hatton, Jacques Lebreton, Richard J Robins

Archives of biochemistry and biophysics 2007;458(2):175-83

Full Text

Abstract

Buflomedil: potential new indications for an old agent.

D Tsantilas, A I Hatzitolios, K Tziomalos, D K Papadimitriou

International angiology : a journal of the International Union of Angiology 2010;28(3):170-4

Full Text

Abstract

A phase I, open-label, single-dose micro tracer mass balance study of C-labeled ASP7991 in healthy Japanese male subjects using accelerator mass spectrometry.

Taiji Sawamoto, Masataka Katashima, Yuta Taniuchi, Kota Kato, Akitsugu Takada, Naoyuki Nakada, Daisuke Miyatake

Drug metabolism and pharmacokinetics 2018;33(2):118-124

Full Text

Abstract

Eletriptan in migraine.

Hans-Christoph Diener

Expert review of neurotherapeutics 2006;5(1):43-53

Full Text

Abstract

Results: 1 – 15 / 234

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Pyrrolidines""[mesh_terms]

5-(pyrrolidin-2-yl)-1H-tetrazole and 5-[(pyrrolidin-2-yl)methyl]-1H-tetrazole: proline surrogates with increased potential in asymmetric catalysis.

Spotlight on intravenous vernakalant in recent-onset atrial fibrillation.

Pharmacokinetics, Pharmacodynamics, and Safety of Evocalcet (KHK7580), a Novel Calcimimetic Agent: An Open-Label, Single- and Multiple-Dose, Phase I Trial in Healthy Chinese Subjects.

Physiologically-Based Pharmacokinetic Model Development, Validation, and Application for Prediction of Eliglustat Drug-Drug Interactions.

Enzyme toolbox: novel enantiocomplementary imine reductases.

Spotlight on eletriptan in migraine.

Bi-atrial high-density mapping reveals inhibition of wavefront turning and reduction of complex propagation patterns as main antiarrhythmic mechanisms of vernakalant.

Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study.

Structure activity relationship (SAR) and anticancer activity of pyrrolidine derivatives: Recent developments and future prospects (A review).

Future target molecules for influenza treatment.

Intravenous vernakalant: a review of its use in the management of recent-onset atrial fibrillation.

Investigation of the mechanism of nicotine demethylation in Nicotiana through 2H and 15N heavy isotope effects: implication of cytochrome P450 oxidase and hydroxyl ion transfer.

Buflomedil: potential new indications for an old agent.

A phase I, open-label, single-dose micro tracer mass balance study of C-labeled ASP7991 in healthy Japanese male subjects using accelerator mass spectrometry.

Eletriptan in migraine.

Results for
""Pyrrolidines""[mesh_terms]